TickerGuard
Buy Day today: Neutral (60) Mixed market breadth · no major macro event
IMTX

Immatics NV

Healthcare · Biotechnology

7.60$ -10.1% vs. previous close Closing price · As of: Oct 2, 2026

Statements

Cash Flow

All figures as the change versus the prior period, in percent. Periods without a positive comparison base stay empty.

Tick rows to compare them in a chart (up to 4)

Cash Flow IMTX
Line item 2018 2019 2020 2021 2022 2023 2024 2025
– +243.1% -220.6% – – -81.8% -967.0% –
– +77.3% +14.7% +18.9% +32.5% +3.8% +69.0% -2.6%
– -42.4% +2,594.0% +15.0% -14.5% -8.3% -14.8% -14.9%
– +129.1% -447.0% – -51.6% – – –
– +97.0% -126.1% – – +119.1% -300.8% –
– +340.6% +236.8% -24.8% +9.9% +398.1% -46.8% -61.8%
– -62.6% +215.3% – -2,899.8% -85.0% +385.5% –
– – – – – – – –
– +0.0% +12.6% +29.2% +5.0% +35.4% -47.7% +47.1%
– -107.9% – -101.3% – -31.7% +278.3% -70.7%
– +106.7% +62.8% -171.5% – +350.6% -73.9% +650.3%
– +240.7% -235.5% – – -113.6% – –

Data as of: October 2, 2026 · Source: fundamental data & SEC filings (annual and quarterly reports, 10-K/10-Q)

Note: pure fact-based analysis, not investment advice and not a solicitation to buy or sell. All figures without guarantee.

Was this page helpful to you?